G1 Therapeutics saw the highest growth of 3.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of G1 Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
G1 Therapeutics has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 67% of filings. The United States(US), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where G1 Therapeutics is filings its patents. Among the top granted patent authorities, G1 Therapeutics has 100% of its grants in Israel(IL).
Roche could be the strongest competitor for G1 Therapeutics
Patents related to rare diseases lead G1 Therapeutics's portfolio
G1 Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Triple-negative breast cancer (tnbc) related patents lead G1 Therapeutics portfolio followed by non-small cell lung cancer, and metastatic transitional (urothelial) tract cancer
G1 Therapeutics has highest number of patents in triple-negative breast cancer (tnbc) followed by non-small cell lung cancer, metastatic transitional (urothelial) tract cancer, diarrhea, and neutropenia.
For comprehensive analysis of G1 Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
